Women’s Health

  • Higher preconception blood pressure linked to pregnancy loss

    on March 30th, 2018
    FROM HYPERTENSION High preconception blood pressure is associated with a greater risk of pregnancy loss, according to analysis of data from a randomized clinical trial of aspirin and pregnancy outcomes. Researchers in the EAGeR (Effects of Aspirin on Gestational and Reproduction) trial analyzed data[...]
  • Oncologist-led BRCA mutation testing and counseling may reduce wait times for women with ovarian cancer

    on March 28th, 2018
    FROM THE JOURNAL OF CLINICAL ONCOLOGY For women with ovarian cancer, an oncologist-led BRCA1/2 (BRCAm) counseling process is associated with favorable waiting times for test results and high levels of satisfaction, according to results of a prospective observational study. The median turnaround time[...]
  • HDAC inhibition may boost immune therapy efficacy in breast cancer

    on March 27th, 2018
    REPORTING FROM THE NCCN ANNUAL CONFERENCE ORLANDO (FRONTLINE MEDICAL NEWS) – The novel combination of entinostat and nivolumab with or without ipilimumab showed encouraging safety, tolerability, and antitumor activity in early results from an ongoing phase 1 trial of patients with advanced breast [...]
  • Sling revisions: pain as indication linked with SUI recurrence

    on March 27th, 2018
    REPORTING FROM SGS 2018 ORLANDO (FRONTLINE MEDICAL NEWS) – Pain as an indication for midurethral sling revision is associated with an elevated risk of postoperative stress urinary incontinence recurrence, according to a review of 129 cases. At a mean follow-up of 21 months, the overall rate of rec[...]
  • Efavirenz-based ART may hamper vaginal ring contraception

    on March 24th, 2018
    REPORTING FROM CROI 2018 BOSTON (FRONTLINE MEDICAL NEWS) – Efavirenz-based antiretroviral therapy may significantly impair the effectiveness of vaginal ring contraceptives, investigators reported. Over a 21-day period, levels of estrogen among women who used a vaginal ring (NuvaRing) while on efav[...]
  • Same-day discharge for hysterectomy

    on March 22nd, 2018
    There is an increased focus on reducing the costs of health care delivery, and one major driver of surgical cost is length of hospitalization. A minimally invasive surgical approach to hysterectomy is a strategy that significantly enhances recovery and shortens hospital stay, although many patients [...]
  • FDA updates breast implant–associated lymphoma cases, risk

    on March 22nd, 2018
    The Food and Drug Administration has received 414 reports of cases of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), including nine deaths. This figure includes all medical device reports received by the agency between 2011 and September 2017. The FDA recently provided an upd[...]
  • Genetic Pap tests catch more cancers

    on March 21st, 2018
    FROM SCIENCE TRANSLATIONAL MEDICINE A Pap test combined with assays for gene mutations showed an 81% and 33% sensitivity or identifying endometrial and ovarian cancer, respectively. In a study published in Science Translational Medicine , Yuxuan Wang, MD , of Johns Hopkins University, Baltimore, and[...]
  • Justices appear skeptical of California’s abortion speech law

    on March 21st, 2018
    A California law that requires anti-abortion crisis pregnancy centers to provide women with information on abortion services was met with skepticism by U.S. Supreme Court justices during March 20 oral arguments. A number of justices, including some considered more liberal-leaning, raised questions a[...]
  • Survey: Litigation fears drive response to FDA power morcellator warnings

    on March 20th, 2018
    REPORTING FROM SGS 2018 ORLANDO (FRONTLINE MEDICAL NEWS) – A 2014 Food and Drug Administration Safety Communication warning about the risk of disseminating occult cancerous tissue when using power morcellation led to a sharp decline in its use among physicians in a large health care system, a surv[...]
  • VIDEO: Fezolinetant drops testosterone levels in PCOS

    on March 19th, 2018
    REPORTING FROM ENDO 2018 CHICAGO (FRONTLINE MEDICAL NEWS) – Testosterone levels dropped by one third for women with polycystic ovary syndrome (PCOS) and hyperandrogenemia when they received a centrally acting medication currently in development. The proof-of-concept phase 2 trial, which saw no con[...]
  • Match Day 2018: Ob.gyn. increases positions and matches

    on March 19th, 2018
    Obstetrics and gynecology helped to make the 2018 Main Residency Match the largest ever as the specialty increased residency slots by 3.7% and accepted 3.3% more applicants, compared with 2017, according to the National Resident Matching Program (NRMP). Ob.gyn. brought 1,336 first-year positions to [...]
  • Popular vaginal dryness products don’t beat placebos

    on March 19th, 2018
    FROM JAMA INTERNAL MEDICINE Estrogen tablets and a popular vaginal gel failed to top placebo for relieving vulvovaginal symptoms in postmenopausal women, based on data from a randomized trial of more than 300 patients suffering from genitourinary syndrome of menopause (GSM), a constellation of sympt[...]
Back to top